PIM kinase inhibitor AZD1208 in conjunction with Th1 cytokines potentiate death of breast cancer cells in vitro while also maximizing suppression of tumor growth in vivo when combined with immunotherapy
- Resource Type
- Article
- Source
- In
Cellular Immunology March-April 2024 397-398 - Subject
- Language
- ISSN
- 0008-8749